首页> 外文OA文献 >Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma

【2h】

Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma

机译：系统地优化的BCMA / CS1双特异性CAR-T细胞鲁棒地控制异质多发性骨髓瘤

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Eugenia Zah; Eunwoo Nam; Vinya Bhuvan; Uyen Tran; Brenda Y. Ji; Stanley B. Gosliner; Xiuli Wang; Christine E. Brown; Yvonne Y. Chen;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma [J] . Eugenia Zah, Eunwoo Nam, Vinya Bhuvan, Nature Communications . 2020,第1期

机译：系统地优化的BCMA / CS1双特异性CAR-T细胞鲁棒地控制异质多发性骨髓瘤
2. REGN5458, a Bispecific BCMAxCD3 T Cell Engaging Antibody, Demonstrates Robust In Vitro and In Vivo Anti-Tumor Efficacy in Multiple Myeloma Models, Comparable to That of BCMA CAR T Cells [J] . Dilillo David J., Olson Kara, Mohrs Katja, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：regn5458是一种双特异性Bcmaxcd3 t细胞接合抗体，在多种骨髓瘤模型中体外和体内抗肿瘤效果稳健地说明了稳健性，与BCMA汽车T细胞相当
3. CAR-T Cells Based on Novel BCMA Monoclonal Antibody Block Multiple Myeloma Cell Growth [J] . Robert Berahovich, Hua Zhou, Shirley Xu, Cancers . 2018,第9期

机译：基于新型BCMA单克隆抗体的CAR-T细胞阻断多发性骨髓瘤细胞生长
4. Development of a Fully Human T-Cell Engaging Bispecific Antibody for the Treatment of Multiple Myeloma [C] . Duy T. Pham, Ben Buelow, Priya Choudry, Protein Engineering Summit. . 2018

机译：开发一种完全人体T细胞接合双特异性抗体治疗多发性骨髓瘤
5. Ex Vivo Maintenance of Primary Human Multiple Myeloma Cells through Optimizing Osteoblastic Niche. [D] . Zhang, Wenting. 2015

机译：通过优化成骨细胞利基的原代人多发性骨髓瘤细胞的体外维持。
6. Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma [O] . Jinhuan Xu, Qiuxiang Wang, Hao Xu, 2018

机译：抗BCMA CAR-T细胞治疗浆细胞异位症：POEMS综合征和多发性骨髓瘤的病例报告
7. Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma [O] . Eugenia Zah, Eunwoo Nam, Vinya Bhuvan, 2020

机译：系统地优化的BCMA / CS1双特异性CAR-T细胞鲁棒地控制异质多发性骨髓瘤

Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma

著录项

引文网络

相似文献

相关主题

期刊订阅